LATEST
Cencora agreed to acquire American Oncology NetworknewAPEX / KorainewSmith & Wesson Brands agreed to acquire Long Range IntermediatenewMaximus Federal Services agreed to acquire Agile DefenseMount Logan Management agreed to acquire Alternative Fund AdvisorsDime Commercial Bancshares / ES BancsharesSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESGMarwynn Holdings acquired Zhituo Software
Open App
ClosedPublished 13 Feb 2023

Oncocyte Corporation /
Chronix

Oncocyte Corporation completed its merger with Chronix

Price
$14m
Stage
Closed
Buy side: Oncocyte Corporation
Buy sideOncocyte Corporation
Target: Chronix
TargetChronix
Source · 13 Feb 2023
See the source
Buy side: Oncocyte Corporation
Buy sideOncocyte Corporation
Target: Chronix
TargetChronix
01 / BuyerOncocyte Corporation
02 / TargetChronix
01

What happened

Oncocyte Corporation completed its merger with Chronix, which became a wholly-owned subsidiary of Oncocyte. The merger was completed on April 15, 2021.

The agreement included potential milestone payments of up to $14 million, along with additional earnout consideration.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Oncocyte Corporation completed its merger with Chronix

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.